SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-283550
Filing Date
2020-11-02
Accepted
2020-11-02 10:02:13
Documents
3
Effectiveness Date
2020-11-02

Document Format Files

Seq Description Document Type Size
1 8-K d198461d8k.htm DEFA14A 20723
2 EX-99.1 d198461dex991.htm EX-99.1 17030
3 GRAPHIC g198461dsp4.jpg GRAPHIC 4720
  Complete submission text file 0001193125-20-283550.txt   45531
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-39059 | Film No.: 201279279
SIC: 3841 Surgical & Medical Instruments & Apparatus